Biomarcadores de las Enfermedades Cardíacas
BIOMARCS
![Foto de Biomarcadores de las Enfermedades Cardíacas](/img/uploaded/e14fc215af57bf9a4f0f552bf7ec9db0.jpg)
![Foto de Massachusetts General Hospital](/img/noimage_org.png)
Massachusetts General Hospital
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Massachusetts General Hospital (5)
2022
-
Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis
JACC: Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1883-1896
2021
-
Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
JACC: Basic to Translational Science, Vol. 6, Núm. 1, pp. 12-21
-
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
Journal of the American College of Cardiology, Vol. 77, Núm. 12, pp. 1503-1516
2004
-
Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques
Circulation, Vol. 110, Núm. 14, pp. 1953-1959
2003
-
Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)
Arteriosclerosis, Thrombosis, and Vascular Biology